Spire Wealth Management’s iShares S&P India Nifty 50 Index Fund INDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,600
Closed -$81.2K 2470
2025
Q1
$81.2K Sell
1,600
-575
-26% -$28.4K ﹤0.01% 1116
2024
Q4
$111K Sell
2,175
-250
-10% -$13.3K ﹤0.01% 1000
2024
Q3
$137K Buy
2,425
+725
+43% +$39.6K ﹤0.01% 830
2024
Q2
$91.2K Hold
1,700
﹤0.01% 921
2024
Q1
$85.7K Buy
1,700
+100
+6% +$4.99K ﹤0.01% 1038
2023
Q4
$79K Buy
1,600
+750
+88% +$34.6K ﹤0.01% 1062
2023
Q3
$38.4K Sell
850
-1,000
-54% -$45.5K ﹤0.01% 1264
2023
Q2
$83.3K Buy
1,850
+1,000
+118% +$42.9K ﹤0.01% 1025
2023
Q1
$34.9K Buy
+850
New +$35.5K ﹤0.01% 1367
2022
Q3
Sell
-850
Closed -$35K 2383
2022
Q2
$35K Hold
850
﹤0.01% 1443
2022
Q1
$39K Hold
850
﹤0.01% 1542
2021
Q4
$40K Hold
850
﹤0.01% 1822
2021
Q3
$44K Hold
850
﹤0.01% 1524
2021
Q2
$40K Hold
850
﹤0.01% 1577
2021
Q1
$38K Buy
+850
New +$38.1K ﹤0.01% 1866

Other funds holding INDY

Spire Wealth Management's INDY Position: Q2 2025 in Review

Spire Wealth Management sold out of iShares S&P India Nifty 50 Index Fund (INDY) in Q2 2025, closing a stake of 1,600 shares — an estimated $81.2K sold.

Spire Wealth Management first reported a position in INDY in Q1 2021 and held it in 15 quarters. The position peaked at $137K in Q3 2024. 102 funds tracked by Wall St. Rank hold INDY as of Q2 2025.

  • Spire Wealth Management reported no remaining iShares S&P India Nifty 50 Index Fund position as of Q2 2025 after selling out during the quarter.
  • Spire Wealth Management sold 1,600 iShares S&P India Nifty 50 Index Fund shares in Q2 2025, an estimated $81.2K.
  • Spire Wealth Management first reported a position in iShares S&P India Nifty 50 Index Fund in Q1 2021 and held it in 15 quarters.
  • Spire Wealth Management's iShares S&P India Nifty 50 Index Fund position peaked at $137K in Q3 2024.
  • 102 funds tracked by Wall St. Rank held iShares S&P India Nifty 50 Index Fund as of Q2 2025.

Based on Spire Wealth Management's 13F filing for Q2 2025, filed 4 Aug 2025.